TYK2 inhibitor 14l   Click here for help

GtoPdb Ligand ID: 11425

Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: 14l is reported as a selective TYK2 inhibitor [2]. It was developed to investigate the anti-inflammatory potential of selective TYK2 inhibition.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 1
Rotatable bonds 7
Topological polar surface area 126.87
Molecular weight 479.08
XLogP 3.06
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES N#CCCn1ncc(c1)c1nc(ncc1F)Nc1ccc2c(c1)ccn2S(=O)(=O)C(F)(F)F
Isomeric SMILES N#CCCn1ncc(c1)c1nc(ncc1F)Nc1ccc2c(c1)ccn2S(=O)(=O)C(F)(F)F
InChI InChI=1S/C19H13F4N7O2S/c20-15-10-25-18(28-17(15)13-9-26-29(11-13)6-1-5-24)27-14-2-3-16-12(8-14)4-7-30(16)33(31,32)19(21,22)23/h2-4,7-11H,1,6H2,(H,25,27,28)
Immunopharmacology Comments
TYK2 mediates signalling of IL-23, IL-12, and Type I IFN-driven responses that are essential drivers in immune-mediated diseases. Selective TYK2 inhibition offers clinical potential for inflammatory diseases, as demonstrated by its efficacy in a mouse colitis model.